Teva Announces Reintroduction of Generic Depo-Provera in the United States

9 years ago

by David Miller

965 Views

Written by David Miller

JERUSALEM–(BUSINESS WIRE)–Sep. 25, 2017– Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced the reintroduction of the generic equivalent to Depo-Provera1 Contraceptive Injection (medroxyprogesterone acetate injectable suspension,…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller